Xiamen Amoytop Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	3,680	2,809	2,093	1,517	1,123
Other Revenue	15.19	7.75	7.74	10	9.51
Revenue	3,696	2,817	2,100	1,527	1,132
Revenue Growth (YoY)	31.18%	34.13%	37.55%	34.86%	42.61%
Cost of Revenue	259.99	183.51	140.2	171.01	126.99
Gross Profit	3,436	2,634	1,960	1,356	1,005
Selling, General & Admin	1,815	1,392	1,060	841.02	700.65
Research & Development	388.03	294.71	228.52	148.58	79.74
Other Operating Expenses	18.68	13.3	10.95	7.64	5.55
Operating Expenses	2,222	1,703	1,300	995.83	783.6
Operating Income	1,214	930.33	659.88	360.06	221.64
Interest Expense	-1.42	-0.45	-0.51	-0.62	-1.07
Interest & Investment Income	10.64	6.99	10.17	8.09	7.84
Currency Exchange Gain (Loss)	-0.38	-0.12	-1.03	0.48	-0.47
Other Non Operating Income (Expenses)	-0.25	-0.09	-0.39	-0.25	-0.24
EBT Excluding Unusual Items	1,222	936.67	668.13	367.77	227.69
Gain (Loss) on Sale of Investments	3.45	0.88	2.65	0.4	1.8
Gain (Loss) on Sale of Assets	-0.99	-0.03	-0.87	0.03	-1.8
Asset Writedown	-	-	-12.76	-	-
Other Unusual Items	-49.28	-6.5	-16.49	-12.27	-12.4
Pretax Income	1,175	931.03	640.65	355.93	215.29
Income Tax Expense	144.14	103.42	85.21	68.91	34.09
Net Income	1,031	827.6	555.45	287.02	181.2
Net Income to Common	1,031	827.6	555.45	287.02	181.2
Net Income Growth	24.61%	49.00%	93.52%	58.40%	55.44%
Shares Outstanding (Basic)	408	408	405	404	403
Shares Outstanding (Diluted)	409	408	405	404	403
Shares Change (YoY)	0.38%	0.56%	0.29%	0.39%	0.18%
EPS (Basic)	2.53	2.03	1.37	0.71	0.45
EPS (Diluted)	2.52	2.03	1.37	0.71	0.45
EPS Growth	24.14%	48.18%	92.96%	57.78%	55.17%
Free Cash Flow	473.23	179.28	223.64	143.99	43.85
Free Cash Flow Per Share	1.16	0.44	0.55	0.36	0.11
Dividend Per Share	0.620	0.620	0.410	0.213	0.100
Dividend Growth	-	51.22%	92.49%	113.00%	100.00%
Gross Margin	92.97%	93.49%	93.33%	88.80%	88.78%
Operating Margin	32.84%	33.02%	31.42%	23.58%	19.57%
Profit Margin	27.91%	29.38%	26.45%	18.80%	16.00%
Free Cash Flow Margin	12.80%	6.36%	10.65%	9.43%	3.87%
EBITDA	1,327	999.36	713.25	403.23	260.33
EBITDA Margin	35.92%	35.47%	33.96%	26.41%	22.99%
D&A For EBITDA	113.79	69.03	53.37	43.17	38.69
EBIT	1,214	930.33	659.88	360.06	221.64
EBIT Margin	32.84%	33.02%	31.42%	23.58%	19.57%
Effective Tax Rate	12.26%	11.11%	13.30%	19.36%	15.83%
Revenue as Reported	3,696	2,817	2,100	1,527	1,132
Advertising Expenses	-	-	-	2.94	5.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.